Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Shares, Euro 0.09 nominal value per share
-
Shares outstanding
-
75,893,250
-
Number of holders
-
66
-
Total 13F shares, excl. options
-
26,784,956
-
Shares change
-
+59,323
-
Total reported value, excl. options
-
$564,348,331
-
Value change
-
+$1,605,878
-
Number of buys
-
37
-
Number of sells
-
-23
-
Price
-
$21.07
Significant Holders of Merus N.V. - Common Shares, Euro 0.09 nominal value per share (MRUS) as of Q2 2021
75 filings reported holding MRUS - Merus N.V. - Common Shares, Euro 0.09 nominal value per share as of Q2 2021.
Merus N.V. - Common Shares, Euro 0.09 nominal value per share (MRUS) has 66 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 26,784,956 shares
of 75,893,250 outstanding shares and own 35.29% of the company stock.
Largest 10 shareholders include BVF INC/IL (7,285,071 shares), FEDERATED HERMES, INC. (2,979,533 shares), WELLINGTON MANAGEMENT GROUP LLP (2,132,233 shares), BAKER BROS. ADVISORS LP (2,037,469 shares), BOXER CAPITAL, LLC (1,900,000 shares), Medicxi Ventures Management (Jersey) Ltd (1,600,000 shares), DRIEHAUS CAPITAL MANAGEMENT LLC (1,004,478 shares), MPM Oncology Impact Management LP (700,879 shares), Avoro Capital Advisors LLC (660,000 shares), and Vivo Capital, LLC (442,000 shares).
This table shows the top 66 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.